← Open Payments lookup

KIRSTEN GILMORE: Open Payments

NPI 1881363786 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$722 in 37 payments from 17 companies in 2025. Trend: 2023 $656 · 2024 $710 · 2025 $722

Food & beverage: $722
CompanyPaymentsAmount
PFIZER INC.4$82
ABBVIE INC.4$80
Astellas Pharma US Inc2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$55
GlaxoSmithKline, LLC.3$52
Novo Nordisk Inc3$50
Lundbeck LLC2$46
Otsuka America Pharmaceutical, Inc.3$44
Lilly USA, LLC2$41
Novartis Pharmaceuticals Corporation2$41

Products named: REXULTI, Veozah, CAPLYTA, NURTEC ODT, LEQVIO, Korlym, TRELEGY ELLIPTA, INGREZZA.

Industry payments across IN — which companies pay providers there.